Literature DB >> 24548058

Degradation of benzodiazepines after 120 days of EMS deployment.

Jason T McMullan, Elizabeth Jones, Bruce Barnhart, Kurt Denninghoff, Daniel Spaite, Erin Zaleski, Robert Silbergleit.   

Abstract

INTRODUCTION: EMS treatment of status epilepticus improves outcomes, but the benzodiazepine best suited for EMS use is unclear, given potential high environmental temperature exposures.
OBJECTIVE: To describe the degradation of diazepam, lorazepam, and midazolam as a function of temperature exposure and time over 120 days of storage on active EMS units.
METHODS: Study boxes containing vials of diazepam, lorazepam, and midazolam were distributed to 4 active EMS units in each of 2 EMS systems in the southwestern United States during May-August 2011. The boxes logged temperature every minute and were stored in EMS units per local agency policy. Two vials of each drug were removed from each box at 30-day intervals and underwent high-performance liquid chromatography to determine drug concentration. Concentration was analyzed as mean (and 95%CI) percent of initial labeled concentration as a function of time and mean kinetic temperature (MKT).
RESULTS: 192 samples were collected (2 samples of each drug from each of 4 units per city at 4 time-points). After 120 days, the mean relative concentration (95%CI) of diazepam was 97.0% (95.7-98.2%) and of midazolam was 99.0% (97.7-100.2%). Lorazepam experienced modest degradation by 60 days (95.6% [91.6-99.5%]) and substantial degradation at 90 days (90.3% [85.2-95.4%]) and 120 days (86.5% [80.7-92.3%]). Mean MKT was 31.6°C (95%CI 27.1-36.1). Increasing MKT was associated with greater degradation of lorazepam, but not midazolam or diazepam.
CONCLUSIONS: Midazolam and diazepam experienced minimal degradation throughout 120 days of EMS deployment in high-heat environments. Lorazepam experienced significant degradation over 120 days and appeared especially sensitive to higher MKT exposure.

Entities:  

Keywords:  benzodiazepines; emergency medical services; temperature

Mesh:

Substances:

Year:  2014        PMID: 24548058      PMCID: PMC4272820          DOI: 10.3109/10903127.2013.869642

Source DB:  PubMed          Journal:  Prehosp Emerg Care        ISSN: 1090-3127            Impact factor:   3.077


  10 in total

1.  Revised USP standards for product dating, packaging, and temperature monitoring.

Authors:  C C Okeke; L Bailey; T Medwick; L T Grady
Journal:  Am J Health Syst Pharm       Date:  2000-08-01       Impact factor: 2.637

Review 2.  Out-of-hospital medication storage temperatures: a review of the literature and directions for the future.

Authors:  Lawrence H Brown; Kurt Krumperman; Christopher J Fullagar
Journal:  Prehosp Emerg Care       Date:  2004 Apr-Jun       Impact factor: 3.077

3.  Structured inspection of medications carried and stored by emergency medical services agencies identifies practices that may lead to medication errors.

Authors:  Douglas F Kupas; Meghan A Shayhorn; Paul Green; Thomas F Payton
Journal:  Prehosp Emerg Care       Date:  2011-10-28       Impact factor: 3.077

4.  Medication storage in the EMS environment: understanding the science and meeting the standards.

Authors:  Lawrence H Brown; James D Campagna
Journal:  Emerg Med Serv       Date:  2005-03

5.  Prehospital stability of diazepam and lorazepam.

Authors:  M D Gottwald; L C Akers; P K Liu; P J Orsulak; M D Corry; P Bacchetti; S M Fields; D H Lowenstein; B K Alldredge
Journal:  Am J Emerg Med       Date:  1999-07       Impact factor: 2.469

6.  Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis.

Authors:  Jason McMullan; Comilla Sasson; Arthur Pancioli; Robert Silbergleit
Journal:  Acad Emerg Med       Date:  2010-06       Impact factor: 3.451

7.  The 60-day temperature-dependent degradation of midazolam and Lorazepam in the prehospital environment.

Authors:  Jason T McMullan; Ashley Pinnawin; Elizabeth Jones; Kurt Denninghoff; Nicholas Siewart; Daniel W Spaite; Erin Zaleski; Robert Silbergleit
Journal:  Prehosp Emerg Care       Date:  2012-11-13       Impact factor: 3.077

8.  A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus.

Authors:  B K Alldredge; A M Gelb; S M Isaacs; M D Corry; F Allen; S Ulrich; M D Gottwald; N O'Neil; J M Neuhaus; M R Segal; D H Lowenstein
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

9.  Intramuscular versus intravenous therapy for prehospital status epilepticus.

Authors:  Robert Silbergleit; Valerie Durkalski; Daniel Lowenstein; Robin Conwit; Arthur Pancioli; Yuko Palesch; William Barsan
Journal:  N Engl J Med       Date:  2012-02-16       Impact factor: 91.245

10.  Stability of tranexamic acid after 12-week storage at temperatures from -20°c to 50°c.

Authors:  Rodolfo de Guzman; I Amy Polykratis; Jill L Sondeen; Daniel N Darlington; Andrew P Cap; Michael A Dubick
Journal:  Prehosp Emerg Care       Date:  2013 Jul-Sep       Impact factor: 3.077

  10 in total
  2 in total

1.  Pre-hospital midazolam for benzodiazepine-treated seizures before and after the Rapid Anticonvulsant Medication Prior to Arrival Trial: A national observational cohort study.

Authors:  Eytan Shtull-Leber; Robert Silbergleit; William J Meurer
Journal:  PLoS One       Date:  2017-03-17       Impact factor: 3.240

2.  Prehospital Care for the Adult and Pediatric Seizure Patient: Current Evidence-based Recommendations.

Authors:  Eric C Silverman; Karl A Sporer; Justin M Lemieux; John F Brown; Kristi L Koenig; Marianne Gausche-Hill; Eric M Rudnick; Angelo A Salvucci; Greg H Gilbert
Journal:  West J Emerg Med       Date:  2017-03-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.